UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Pharmaceuticals, CROs have hard time doing clinical trials amid prolonged pandemic
Amid the protracted Covid-19 pandemic, pharmaceutical and contract research...
by Lee Han-soo
|
2020-09-03 19:24
라인
8 in 10 clinical professors willing to act collectively
About 80 percent of medical school professors across the nation said they w...
by Song Soo-youn
|
2020-09-03 16:29
라인
Daewoong to expand indication of Nabota in US
Daewoong Pharmaceutical said it would enter the treatment market for botuli...
by Lee Han-soo
|
2020-09-03 12:13
라인
New virus cases fall below 200 but critical patients surge
Korea's new Covid-19 cases fell to the lowest level in more than two we...
by Lee Han-soo
|
2020-09-03 11:27
라인
Nation struggles to secure beds, workforce for severe Covid-19 patients
The Ministry of Health and Welfare is securing more sickbeds and training m...
by Shim Hyun-tai
|
2020-09-02 16:15
라인
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
Researchers at Seoul National University Bundang Hospital (SNUBH) have deve...
by Lee Han-soo
|
2020-09-02 15:20
라인
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
JW Pharmaceutical said Tuesday that its rheumatoid arthritis drug, Actemra ...
by Shim Hyun-tai
|
2020-09-02 14:08
라인
[Column] Correct diagnosis leads to proper treatment
The clash between the government and the medical community over the issue o...
by Shin Eui-cheol
|
2020-09-02 13:10
라인
FDA grants priority review to Hanmi’s Oraxol
Hanmi said the U.S. Food and Drug Administration has approved the new drug ...
by Lee Han-soo
|
2020-09-02 13:06
라인
New virus cases slow down – for now
Korea reported new Covid-19 cases of below 300 for the fourth day on Wednes...
by Lee Han-soo
|
2020-09-02 11:06
라인
Korea’s annual healthcare conference to go online only
The Korea Biotechnology Industry Organization (KBIO) said the upcoming annu...
by Kim Chan-hyuk
|
2020-09-02 11:05
라인
Korea approved 22 clinical studies for Covid-19 vaccines, treatments
The Ministry of Food and Drug Safety said it has approved 22 clinical trial...
by Shim Hyun-tai
|
2020-09-01 18:02
라인
State researchers develop more accurate gene scissor tech
The Korea Research Institute of Bioscience & Biotechnology (KRIBB) said its...
by Lee Han-soo
|
2020-09-01 18:01
라인
MedPacto’s oncology pipeline for blood cancer wins EU patent
MedPacto said Tuesday that it has obtained a European patent for a pharmace...
by Shim Hyun-tai
|
2020-09-01 17:14
라인
AZ requests court to nullify Dong-A ST’s avoidance of Forxiga patent
AstraZeneca filed a suit with the Patent Court to cancel the Intellectual P...
by Kim Yun-mi
|
2020-09-01 15:40
라인
'Malaria treatment plus nanotech increases radiation cancer treatment’s effect'
Researchers at the National Cancer Center have proved that a porous nanobal...
by Lee Han-soo
|
2020-09-01 15:40
라인
MSD’s antiviral Prevymis gains insurance coverage
MSD Korea said that the Ministry of Health and Welfare has granted insuranc...
by Shim Hyun-tai
|
2020-09-01 15:05
라인
T&R Biofab gains sales rights of pluripotent stem cell-derived cardiomyocyte
T&R Biofab has signed a licensing agreement with iPS Academia Japan to secu...
by Shim Hyun-tai
|
2020-09-01 14:13
라인
LG Chem, SK Bioscience end sales partnership with Daewoong
Two leading local pharmaceutical firms, LG Chem and SK Bioscience, have rec...
by Kim Chan-hyuk
|
2020-09-01 14:12
라인
LSK Global PS to conduct P3 trial of Sinovac's Covid-19 vaccine candidate
LSK Global Pharma Services said that it would conduct the phase 3 clinical ...
by Lee Han-soo
|
2020-09-01 12:17
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top